Physician profile
Arshad Muzaffar
NPI 1881621001
$4,015.82
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,129 · 2020: $300 · 2021: $1,200 · 2022: $76.55 · 2023: $62.13 · 2024: $129 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,400.00 | 2019-2020 | |
| Elite Orthopedics, LLC | $1,255.46 | 2021-2025 | |
| Integra Lifesciences Corporation | $113.65 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Endo USA, INC. | $55.67 | 2025 | Xiaflex |
| Mentor Worldwide LLC | $53.79 | 2022-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $28.71 | 2019 | |
| Tela Bio, INC. | $24.95 | 2024 | Ovitex 2s |
| Sientra, INC. | $22.63 | 2022 | |
| Polynovo North America LLC | $21.54 | 2025 | Novosorb Btm |
| Abbvie INC. | $20.35 | 2023 | |
| Endo Pharmaceuticals INC. | $19.07 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshad Muzaffar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.